Process for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds

US9850198B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9850198-B2
Application numberUS-201615157216-A
CountryUS
Kind codeB2
Filing dateMay 17, 2016
Priority dateJun 15, 2010
Publication dateDec 26, 2017
Grant dateDec 26, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A process for the preparation of substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds which has advantages over conventional processes with respect to higher conversions and yields, flexibility, a shorter overall route, environmentally acceptable conditions, influence of stereoselectivity such as diastereoselectivity in a targeted manner and at least partial suppression of the formation of undesired side-products and/or undesired stereoisomers, in particular undesired diastereomers.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of preparing a compound according to formula (I) wherein R 1 , R 2 , and R 3 are each independently selected from H or C 1-4 aliphatic residues, or a physiologically acceptable acid addition salt thereof, said method comprising the steps of: hydrogenating a compound according to formula (C—I) wherein R 3 is defined above, to a compound a according to formula (C-II) wherein R 3 is defined as above, substituting at least one hydrogen atom of the primary amine group of the compound according to formula (C-II) with a C 1-4 aliphatic residue to form the compound according to formula (I), and optionally converting the compound according to formula (I) into a physiologically acceptable acid addition salt thereof. 2. The method according to claim 1 , wherein said compound is in the form of an isolated stereoisomer. 3. The method according to claim 2 , wherein said compound is in the form of an isolated enantiomer or diastereomer. 4. The method according to claim 1 , wherein said compound is in the form of a mixture of stereoisomers in any mixing ratio. 5. The method according to claim 4 , wherein said compound is in the form of a racemic mixture of stereoisomers. 6. The method according to claim 1 , wherein the hydrogenation is effected by a homogeneous or heterogeneous catalyst in the presence of hydrogen. 7. The method according to claim 6 , wherein the homogenous catalyst is a transition metal complex. 8. The method according to claim 7 , wherein the transition metal complex includes rhodium, iridium or ruthenium, or rhodium with diphosphine ligands, wherein the diphosphine ligands. 9. The method according to claim 7 , wherein the homogeneous catalyst is rhodium (−)-DIPAMP [(R,R)-(+1,2-Bis[(2-methoxyphenyl)(phenyl)phosphino]ethane], rhodium (+)-DIPAMP [(S, S)-(+)-1,2-Bis[(2-methoxyphenyl(phenyl)phosphino]ethane], rhodium R-Solphos [R-(+)-N,N′-Dimethyl-7,7′-bis(diphenylphosphino)-3,3′,4,4′-tetrahydro-8,8′-bi-2H-1,4-benzoxazine ]or rhodium S-Solphos [S-(−)-N,N′-Dimethyl-7,7′-bis(diphenylphosphino)-3,3′,4,4′-tetrahydro-8,8′-bi-2H-1,4-benzoxazine]. 10. The method according to claim 6 , wherein the heterogeneous catalyst is one or more transition metals, wherein the one or more transition metals is in the same or different oxidation states or in two or more different oxidation states. 11. The method according to claim 10 , wherein the heterogeneous catalyst is Raney nickel, palladium, palladium on carbon, platinum, platinum on carbon, ruthenium on carbon or rhodium on carbon. 12. The method according to claim 1 , wherein the compound according to formula (C-II) is optionally converted into a physiologically acceptable acid addition salt. 13. The method according to claim 1 , wherein the compound according to formula C-I is prepared according to the following steps: desiylating a compound according to formula (C-0-I) wherein R 3 is H or a C 1-4 aliphatic residue, and R a , R b , R c is C 1-8 aliphatic residue or aryl, to a compound according to formula (C-0-II) and dehydrating the compound according to formula (C-0-II) to the compound according to formula (I). 14. The method according to claim 13 , wherein the compound according to formula (C-0-I) and (C-0-II) are produced into the compound according to formula (I) without any isolation steps. 15. The method according to claim 13 , wherein the desilylating is acid catalyzed, acid promoted or performed in the presence of a fluoride source or optionally in the presence of a base when R a , R b , R c is each methyl. 16. The method according to claim 13 , wherein the desilylating is acid catalyzed in the presence of a catalytically effective or at least stoichiometric amount of an acid selected from formic acid, hydrochloric acid, acetic acid, sulfuric acid, hydrobromic acid, methanesulfonic acid, phosphoric acid, or combinations thereof. 17. The method according to claim 13 , wherein the dehydrating is acid catalyzed or acid promoted in the presence of a catalytically effective or at least stoichiometric amount of an acid selected from formic acid, hydrochloric acid, acetic acid, sulfuric acid, hydrobromic acid, methanesulfonic acid, p-toluenesulfonic acid, phorphorous pentoxide, thionyl chloride, phosphoryl chloride, or combinations thereof. 18. The method according to claim 13 , wherein any one of the compounds according to formula (C-I), (C-II), (C-0I), (C-0-II), or (I), wherein R 3 is not hydrogen, undergoes deprotecting to produce a compound according to formula (Ib) 19. The method according to claim 18 , wherein the compound according to formula (C-I), (C-II), or (I) undergoes deprotecting. 20. The method according to claim 13 , wherein the compound according to formula (C-I) is produced according to the following steps: reacting a compound according to formula (C-0-III) wherein R 3 is a H or a C 1-4 aliphatic residue with a compound having a formula SiR a R b R c (CN), wherein R a , R b , R c are each independently selected from C 1-8 aliphatic residues or aryl, to produce a compound, according to formula (C-0-I). 21. The method according to claim 20 , wherein the compound according to formula SiR a R b R c (CN) is trimethylsilylcyanide, triethylsilylcyanide, tri-n-propylsilylcyanide or triisopropylsilylcyanide. 22. The method according to claim 1 , wherein R 1 and R 2 of formula (I) are each selected from H, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl or tert-butyl; R 3 of formula (I) is selected from H, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, or tert-butyl. 23. The method according to claim 1 , wherein R 1 and R 2 of formula (I) are each selected from H or methyl; and R 3 of formula (I) is selected from H or methyl.

Assignees

Inventors

Classifications

  • C07C213/08Primary

    by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups · CPC title

  • linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring · CPC title

  • by reactions not involving the formation of carboxamide groups · CPC title

  • linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring · CPC title

  • Optical isomers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9850198B2 cover?
A process for the preparation of substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds which has advantages over conventional processes with respect to higher conversions and yields, flexibility, a shorter overall route, environmentally acceptable conditions, influence of stereoselectivity such as diastereoselectivity in a targeted manner and at least partial suppression of the formation…
Who is the assignee on this patent?
Gruenenthal Gmbh
What technology area does this patent fall under?
Primary CPC classification C07C213/08. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).